In March 2024, the ZKBS upgraded the Ba/F3 cell line due to positive detection of reverse transcriptase activity.
Share
Ba/F3is an IL-3-dependentPro-B cell linefrom the mouse, which is a frequently used system in oncology research. Ba/F3 cells are used, among other things, to characterize cellular kinases and their kinase inhibitors.
The origin of the Ba/F3 cell line was initially unclear, as they were originally described as IL-3-dependent pro-B cells derived from the bone marrow of Balb/c mice. However, subsequent genotyping of the Ba/F3 cells revealed that they were actually isolated from a C3H mouse.
In recent analyses (PCR and ELISA tests) in the laboratories of the German Collection of Microorganisms and Cell Cultures (DSMZ), the activity of areverse transcriptasein Ba/F3 cell lysates. This result indicates the presence of a previously unidentified endogenousRetrovirusin the cells. As a consequence, the ZKBS has transferred the cell line to theRisk group 2upgraded. For re-evaluation, the ZKBS may receive its own data on the characterization of the endogenous retrovirus from Ba/F3 cells in the future.